MoonLake Immunotherapeutics (MLTX) Q4 2025 Earnings

Nov 5Confirmed
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-1.1
-0.94
-0.78
-0.62

Details

Expected EPS
-0.878837
Actual EPS
-1.1
Surprise EPS
-0.22
Surprise Percent
-25.17%

Description

⁨MoonLake Immunotherapeutics⁩ (⁦MLTX⁩) has reported earnings of ⁦-1.1⁩ per share for ⁦Q4 2025⁩.

0 Comments

Share your thoughts